Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $578.26 thousand as of January 22, 2025. Its market cap has decreased by -54.42% in one year.

Market Cap

578.26K

Enterprise Value

940.24K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.17

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 578.26K, a decrease of -99.66%. That is a compound annual growth rate of -41.97%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	578.26K	53.85%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.99B
Veradigm	1.54B
SS Innovations International	1.46B
Nika Pharmaceuticals	603.98M
Elite Pharmaceuticals	526.28M
Glass House Brands	431.12M
Northwest Biotherapeutics	367.83M
BioStem Technologies	264.80M

Market Cap Rankings